Domov › Ulcerózna kolitída › North Carolina
Klinické štúdie Ulcerózna kolitída v štáte North Carolina
23 štúdií pre Ulcerózna kolitída hľadá účastníkov v zariadeniach v štáte North Carolina.
Mestá v štáte North Carolina
- Durham10 štúdií
- Charlotte7 štúdií
- Wilmington4 štúdií
- Fayetteville4 štúdií
- Raleigh3 štúdií
- Greenville3 štúdií
Oficiálny text štúdie (anglicky)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Digestive Health Partners /ID# 280490, Asheville
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Charlotte Gastroenterology and Hepatology, P.L.L.C, Charlotte
- Carolina Digestive Diseases, Greenville
- Piedmont Healthcare, Statesville
- a 1 ďalších
Prebieha náborFáza 4
Vek 18 až 80 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06581328Confirmatory Clinical Study in Active Ulcerative Colitis
- Cross Creek Medical Clinic, Fayetteville
- Peters Medical Research, High Point
Prebieha náborFáza 2
Vek 16 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07296315A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- University of North Carolina, Chapel Hill
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Raleigh
Prebieha náborFáza 1/2Vítaní zdravých dobrovoľníkov
Vek 18 až 75 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- 040, Chapel Hill
- Site 041, Durham
- Site 016, Winston-Salem
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07012395A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Monroe Biomedical Research, Monroe
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- University of North Carolina, Chapel Hill
- Atrium Health, Charlotte
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Coastal Research Institute - Fayetteville, Fayetteville
Prebieha náborFáza 3
Vek 18 až 70 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06937086LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Carolina Digestive Diseases and Endoscopy Center, Greenville
- Wilmington Health, PLLC, Wilmington
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Digestive Health Partners, Asheville
- University of North Carolina, Chapel Hill
Prebieha náborFáza 4
Vek 18 až 65 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Cross Creek Medical Clinic - Site Number: 8400057, Fayetteville
Prebieha náborFáza 3
Vek 16 až 80 · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07185009A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- University of North Carolina at Chapel Hill, Chapel Hill
Prebieha náborFáza 4
Vek 18 a viac · Ženy · Aktualizované 28. 8. 2026 · NCT07654751A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Atrium Health Gastroenterology and Hepatology, Charlotte
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 21. 8. 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- UNC Hospitals, The University of North Carolina at Chapel Hill - Site Number: 8400074, Chapel Hill
- OnSite Clinical Solutions - Site Number: 8400051, Charlotte
- Duke University Medical Center - Site Number: 8400093, Durham
- a 3 ďalších
Prebieha náborFáza 3
Vek 16 až 80 · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT07184996BOOM-IBD2 Pivotal Clinical Trial
- UNC Chapel Hill, Chapel Hill
Prebieha nábor
Vek 18 až 85 · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT06571669Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of North Carolina, Chapel Hill
- Atrium Health Center for Gastroenterology and Surgery, Charlotte
- Wake Forest School of Medicine, Winston-Salem
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 8. 2026 · NCT07237516An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill
- OnSite Clinical Solutions, LLC, Charlotte
Prebieha náborObservačná štúdia
Vek 18 až 64 · Všetky pohlavia · Aktualizované 9. 7. 2026 · NCT06398626A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
- PPD Virtual - PPD - US, Wilmington
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Ženy · Aktualizované 15. 6. 2026 · NCT05953402A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, High Point
- Mirador Therapeutics Selected Site, Raleigh
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 12. 3. 2026 · NCT07113522Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 010, Greenville
Prebieha náborFáza 4
Vek 5 až 17 · Všetky pohlavia · Aktualizované 16. 9. 2025 · NCT04314375Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- University of North Carolina, Chapel Hill
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 5. 2025 · NCT06750731IBD Pregnancy Registry
- PPD, Wilmington
Prebieha náborObservačná štúdia
Vek 18 až 50 · Ženy · Aktualizované 4. 4. 2025 · NCT06910553Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.